NCT04119024 2026-03-17Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsStanford UniversityPhase 1 Recruiting18 enrolled
NCT04907643 2026-02-20Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesCedars-Sinai Medical CenterPhase NA Recruiting360 enrolled
NCT03452774 2025-10-28SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryMassive Bio, Inc.Recruiting50,000 enrolled
NCT06358001 2025-09-22EchoTip AcuCore Post-Market Clinical StudyCook Group IncorporatedCompleted183 enrolled
NCT06577987 2025-09-15Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor MalignanciesCircle PharmaPhase 1 Recruiting220 enrolled
NCT04579757 2025-05-08Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid TumorsHutchmedPhase 1/2 Terminated87 enrolled 29 charts